The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
Activity Number:
|
522
|
Type:
|
Contributed
|
Date/Time:
|
Wednesday, August 1, 2012 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #304097 |
Title:
|
Development of Software for Simulation and Implementation of Optimal Response-Adaptive Randomization Designs in Time-to-Event Trials
|
Author(s):
|
Oleksandr Sverdlov*+ and Yevgen Ryeznik and Weng-Kee Wong
|
Companies:
|
Bristol-Myers Squibb and Kharkov National University of Economics and University of California at Los Angeles Fielding School of Public Health
|
Address:
|
Route 206 & Province Line Road, Princeton, NJ, 08543, United States
|
Keywords:
|
Adaptive design ;
Optimal allocation ;
Multiple-objective clinical trial ;
Time-to-event outcome ;
Randomization design
|
Abstract:
|
Response-adaptive randomization (RAR) designs are becoming increasingly popular in clinical trial practice due to their ability to handle multiple experimental objectives simultaneously. In this talk, we describe user interface software developed in MATLAB to facilitate implementation of optimal RAR designs in multi-arm clinical trials with multiple objectives and censored time-to-event primary outcomes. Our software has the following important utilities: 1). It can compute different types of optimal treatment allocation ratios for a user-defined set of experimental parameters. 2). It can simulate RAR procedures targeting selected optimal allocations. The simulated design characteristics include summary statistics and graphical displays of the distributions of treatment allocation proportions, estimators of the model parameters, design efficiencies, and ethical criteria. 3). It allows interactive recalculation of treatment randomization probabilities given history of treatment assignments and responses from patients in the trial. We demonstrate the utility of our software by redesigning a time-to-event clinical trial from the literature and make specific comparisons.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.